The COVID-19 pandemic: A community approach

Paolo Cravedi¹, Jesse D Schold², Kassem Safa³, Olivia S Kates⁴, Nissreen Elfadawy⁵, Roslyn B Mannon⁶, Malay B Shah⁷, Sarah P Hammond⁸, Robin Avery⁹, Cesar Guerrero Miranda¹⁰, Leonardo V Riella¹¹, Sheila Jowsey-Gregoire¹², Enver Akalin¹³, Geoffrey Camirand¹⁴, Maria-Luisa Alegre¹⁵, Jamil Azzi¹¹

Affiliations

¹ Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
² Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
³ Transplant Center and Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
⁵ Division of Nephrology, Hypertension and Kidney Transplant, Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland, OH, USA.
⁶ Division of Nephrology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
⁷ Division of Transplantation, Department of Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
⁸ Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁹ Division of Infectious Diseases, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
¹⁰ Baylor Scott and White Heart and Vascular Hospital, Dallas, TX, USA.
¹¹ Transplanation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
¹² Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
¹³ Albert Einstein College of Medicine, Montefiore Medical Center, New York City, NY, USA.
¹⁴ The Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical, Pittsburgh, PA, USA.
¹⁵ Department of Medicine, University of Chicago, Chicago, IL, USA.

PMID: 32762055
PMCID: PMC7435543
DOI: 10.1111/ctr.14059

Review

The COVID-19 pandemic: A community approach

Paolo Cravedi et al. Clin Transplant. 2020 Nov.

. 2020 Nov;34(11):e14059.

doi: 10.1111/ctr.14059. Epub 2020 Sep 28.

Authors

Affiliations

¹ Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
² Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
³ Transplant Center and Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
⁵ Division of Nephrology, Hypertension and Kidney Transplant, Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland, OH, USA.
⁶ Division of Nephrology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
⁷ Division of Transplantation, Department of Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
⁸ Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁹ Division of Infectious Diseases, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
¹⁰ Baylor Scott and White Heart and Vascular Hospital, Dallas, TX, USA.
¹¹ Transplanation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
¹² Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
¹³ Albert Einstein College of Medicine, Montefiore Medical Center, New York City, NY, USA.
¹⁴ The Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical, Pittsburgh, PA, USA.
¹⁵ Department of Medicine, University of Chicago, Chicago, IL, USA.

PMID: 32762055
PMCID: PMC7435543
DOI: 10.1111/ctr.14059

Abstract

An unprecedented global pandemic caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has quickly overwhelmed the health care systems worldwide. While there is an absence of consensus among the community in how to manage solid organ transplant recipients and donors, a platform provided by the American Society of Transplantation online community "Outstanding Questions in Transplantation," hosted a collaborative multicenter, multinational discussions to share knowledge in a rapidly evolving global situation. Here, we present a summary of the discussion in addition to the latest published literature.

Keywords: immune deficiency; immunosuppressant; infection and infectious agents.

PubMed Disclaimer

Conflict of interest statement

None.

References

1. Cucinotta D, Vanelli M. WHO declares COVID‐19 a pandemic. Acta Biomed. 2020;91(1):157‐160. - PMC - PubMed
1. Alberici F, Delbarba E, Manenti C, et al. Management of patients on dialysis and with kidney transplant during SARS‐COV‐2 (COVID‐19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580‐585. - PMC - PubMed
1. Columbia University Kidney Transplant P . Early description of coronavirus 2019 disease in kidney transplant recipients in New York. J Am Soc Nephrol. 2020;31(6):1150‐1156. - PMC - PubMed
1. Available at https://wwwworldometersinfo/coronavirus/about/. Accessed April 23, 2020.
1. Omer SB, Malani P, Del Rio C. The COVID‐19 pandemic in the US: a clinical update. JAMA. 2020;323(18):1767‐1768. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The COVID-19 pandemic: A community approach

Affiliations

The COVID-19 pandemic: A community approach

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous